Leading traditional therapy drugs in the U.S. by PMPY spending 2016
This statistic shows the leading 10 therapeutic drugs in the United States in 2016, based on per-member-per-year spending. The drug Lantus (insulin glargine) for diabetes had the highest PMPY spending, reaching almost 17 U.S. dollars in that year.